Joseph Shulman, Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 10,626 shares at $50.01 ($531K) on 2024-07-12, disclosed to the SEC on 2024-07-16.
Scheduled sale ($531k) by Chief Technical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.01 | 5,313 | $266K | 50.0% |
| 2 | $50.01 | 5,313 | $266K | 50.0% |
| Total | $50.01 avg | 10,626 | $531K | 100% |
| Filing → |
| RYTM | SELL | 2025-10-30 | $648K | — | Filing → |
| RYTM | SELL | 2025-10-20 | $3.2M | — | Filing → |
| RYTM | SELL | 2025-09-04 | $3.5M | — | Filing → |